biote Corp. (BTMD) stock
BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3069% below fair value
$0.99+0.03 (+3.09%)
Close on Nov 17, 2026Market cap $35.57MP/E 9.9Yield –
biote pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
biote's pe ratio was 10.9× on Nov 11, 2026, against 3.4× a year earlier. Over the last 3 years it ranged from 1.8× to 654.6×, with a median of 16.4×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 10.9× | +7.6 |
| 2025 | Dec 31, 2025 | 3.3× | −25.5 |
| 2024 | Dec 31, 2024 | 28.8× | −625.8 |
| 2022 | Oct 31, 2022 | 654.6× | – |
See a number that looks wrong?